Valuation: Enovis Corporation

Market Cap 1.36B 1.19B 1.1B 1.02B 1.93B 130B 1.97B 13.24B 5.14B 63.74B 5.11B 5B 221B P/E 2026 *
194x
P/E 2027 * 24.5x
Enterprise Value 2.56B 2.24B 2.07B 1.91B 3.63B 245B 3.7B 24.9B 9.67B 120B 9.6B 9.39B 416B EV / Sales 2026 *
1.09x
EV / Sales 2027 * 0.98x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day-7.41%
1 week+17.91%
Current month+14.15%
1 month-0.21%
3 months-0.67%
6 months-18.04%
Current year-11.30%
1 week 22.93
Extreme 22.93
26.5
1 month 19.14
Extreme 19.14
26.5
Current year 19.14
Extreme 19.14
29.89
1 year 19.14
Extreme 19.14
36.82
3 years 19.14
Extreme 19.14
66.14
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/06Free

Director

846 0.0015%
15/06Buy

Chief Administrative Officer

1,000 0.0017%
11/06Free

Chief Administrative Officer

1,000 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-7.41%+17.91%-31.98%-63.24% 1.36B
-0.88%+4.29%-16.08%+11.07% 125B
-1.15%-1.24%-0.22%-4.96% 12.69B
+1.53%+11.19%+49.33%+120.94% 8.98B
-0.46%-3.64%-50.04%-73.25% 3.85B
-1.81%+1.31%+19.53%+40.77% 2.6B
-1.60%-5.04%-12.86%-19.85% 1.77B
-1.01%-1.14%-3.26%-25.57% 1.6B
-1.56%+8.45%-63.06%-84.17% 1.42B
Average -1.59%+4.06%-12.07%-10.92% 17.73B
Weighted average by Cap. -0.84%+4.32%-11.77%+12.24%

Financials

2026 *2027 *
Net sales 2.34B 2.06B 1.9B 1.75B 3.33B 225B 3.39B 22.82B 8.87B 110B 8.8B 8.61B 381B 2.47B 2.16B 2B 1.85B 3.5B 236B 3.57B 24.01B 9.33B 116B 9.26B 9.06B 401B
Net income 2.96M 2.6M 2.4M 2.21M 4.2M 283M 4.28M 28.81M 11.2M 139M 11.12M 10.87M 481M 54.22M 47.56M 43.91M 40.57M 76.9M 5.19B 78.44M 528M 205M 2.54B 204M 199M 8.82B
Net Debt 1.2B 1.05B 970M 896M 1.7B 115B 1.73B 11.66B 4.53B 56.1B 4.5B 4.4B 195B 1.07B 935M 863M 798M 1.51B 102B 1.54B 10.38B 4.03B 49.95B 4B 3.92B 173B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
08/07/26 USD 23.63 -7.41% 1,213,833
07/07/26 USD 25.52 -1.47% 989,227
06/07/26 USD 25.90 +15.11% 2,155,004
02/07/26 USD 22.50 +12.28% 1,302,522
01/07/26 USD 20.04 -3.19% 1,502,881
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
23.63USD
Average target price
41.90USD
Spread / Average Target
+77.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock